Guggenheim Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $90

Futu NewsJan 9 07:32 · Ratings

Citi Maintains Celldex Therapeutics(CLDX.US) With Buy Rating, Maintains Target Price $70

Futu NewsJan 9 01:33 · Ratings

Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors

BenzingaJan 8 23:23

Calculating The Intrinsic Value Of Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Simply Wall StJan 4 21:12

Is There An Opportunity With Celldex Therapeutics, Inc.'s (NASDAQ:CLDX) 26% Undervaluation?

Yahoo FinanceJan 1 19:33

Express News | Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis

BreakingsDec 19, 2024 21:01